| Application no. and date | 17151756.8 (espacenet) (Federated) (European Patent Register), 20090625 | | Patent/reg. no. and date | DK/EP 3216803, 20200311 | | Publication date | 20170913 | | Priority no. and date | US 75697 P, 20080625, US 75692 P, 20080625, US 133212 P, 20080625, US 155041 P, 20090224 | | EP pub. no. and date |
EP 3216803 20170913 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/160506 | | Inventor | URECH, David, c/o ESBATech, an Alcon Biomedical
Research Unit LLC
Wagistrasse 21
8952 Schlieren, CH,
BORRAS, Leonardo, lichtstrasse 35
4056 Basel, CH,
GUNDE, Tea, c/o ESBATech, an Alcon Biomedical Research Unit LLC
Wagistrasse 21
8952 Schlieren, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/22 (2006.01) | | Title | Stabile og opløselige antistoffer, der hæmmer vegf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
